Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?
Am J Hematol
; 99(8): 1450-1453, 2024 08.
Article
en En
| MEDLINE
| ID: mdl-38752361
ABSTRACT
Asprin dosing strategy in low risk (young and JAK2 mutated without history of thrombosis) or very low risk (young JAK2 wild-type without history of thrombosis) essential thrombocythemia.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Aspirina
/
Janus Quinasa 2
/
Trombocitemia Esencial
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article